http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-27920-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2003-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb80b9def652a2538433c0d20fddf739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c94732283a4b4e9a8bdbdefa77d66b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0900b8a303b53a6014859b22076cd10
publicationDate 2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-27920-A1
titleOfInvention COMBINATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLEDHEDRINE AS NEW PHARMACEUTICAL FORMULATIONS
abstract The present invention relates to novel oral pharmaceutical compositions comprising as pharmaceutically active compounds a combination of an effective adtihistamine amount of epinastine or a pharmaceutically acceptable salt thereof and an effective decongestant amount of pseudoephedrine or one of its pharmaceutically acceptable salts and methylephedrine (methylephrine (methylephrine) ) in an effective decongestant amount or one of its pharmaceutically acceptable salts. The formulation further comprises pharmaceutically acceptable carriers or excipients.
priorityDate 2002-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415807347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3241

Total number of triples: 46.